Tom Nolan reviews this week’s research An editorial about D-dimers likens the endlessly talked about blood test to a fine wine. It’s nothing to do with its taste (I find it a bit claggy) or cost, but ...
Please provide your email address to receive an email when new articles are posted on . Continuous anticoagulation significantly decreased the rate of deep vein thrombosis and pulmonary embolism.
Over the past 40 years, major changes have occurred in the area of anticoagulation management. New strategies have been developed for older anticoagulants, older beliefs have been challenged, new ...
Objective: To provide recommendations for optimized anticoagulant therapy in the inpatient setting and outline broad elements that need to be in place for effective management of anticoagulant therapy ...
Our extensive research on the United States Anticoagulation Therapy (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, inv ...
Oral anticoagulant use was associated with a reduced risk for progression of 60% and a reduced risk for death of 76% in ...
Therapeutic-dose anticoagulation with heparins reduced 28-day mortality compared with prophylactic doses in patients hospitalized with COVID-19. Higher-dose anticoagulation was associated with a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients hospitalized with COVID-19 who received ...
Background: Patients taking oral anticoagulant therapy balance the risks of hemorrhage and thromboembolism. We sought to determine the association between anticoagulation intensity and the risk of ...
Venous thromboembolism (VTE) is a major cause of morbidity and mortality in patients with cancer. Primary prevention with pharmacologic agents (or mechanical methods, if anticoagulants are ...
For patients younger than 21 who have provoked venous thromboembolism (VTE), shortening the length of anticoagulation to prevent a recurrent event is no worse than using it for the standard 3 months, ...
Patients at high risk for thromboembolism who undergo aortic valve replacement with a mechanical valve can safely take less than the standard dose of warfarin after 3 months, according to results of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback